Section Arrow
APLT.NASDAQ
- Applied Therapeutics
Quotes are at least 15-min delayed:2024/05/16 18:42 EDT
Last
 4.25
-0.15 (-3.41%)
Day High 
4.51 
Prev. Close
4.4 
1-M High
5.29 
Volume 
823.33K 
Bid
4.18
Ask
4.67
Day Low
4.23 
Open
4.39 
1-M Low
4.165 
Market Cap 
502.78M 
Currency USD 
P/E -- 
%Yield
10-SMA 4.61 
20-SMA 4.5 
50-SMA 5.46 
52-W High 9.39 
52-W Low 1.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.91/-0.59
Enterprise Value
502.81M
Balance Sheet
Book Value Per Share
0.59
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.99M
Operating Revenue Per Share
0.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1001+0.0224+28.83%-- 
DNAGinkgo Bioworks Holdings0.839-0.0001-0.01%-- 
NBYNovaBay Pharmaceuticals0.12+0.0155+14.83%-- 
JAGXJaguar Health0.2867+0.0316+12.39%-- 
NVAXNovavax14.4+1.5+11.63%-- 
Quotes are at least 15-min delayed:2024/05/16 18:42 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.